{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:20:43Z","timestamp":1792725643192,"version":"4.5.0"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/23710-8"],"award-info":[{"award-number":["2024\/23710-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/16573-3"],"award-info":[{"award-number":["2020\/16573-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118575","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:21:40Z","timestamp":1768234900000},"page":"118575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Structure function and design of polymyxins to enable safer and more potent anti Gram negative agents"],"prefix":"10.1016","volume":"305","author":[{"given":"Hassan","family":"Gamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-0383","authenticated-orcid":false,"given":"Cesar Augusto","family":"Roque-Borda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz G.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Albericio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118575_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tim.2018.02.006","article-title":"Towards understanding MCR-like Colistin resistance","volume":"26","author":"Sun","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2026.118575_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/jms.jms_112_16","article-title":"Assessment of the inequalities in the immunization coverage. World health organization","volume":"32","author":"Shrivastava","year":"2018","journal-title":"J. Med. Soc."},{"key":"10.1016\/j.ejmech.2026.118575_bib4","unstructured":"O\u2019Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance; May 2016. p. 1\u201384. Available from: https:\/\/apo.org.au\/node\/63983 (accessed 25 December 2025)."},{"key":"10.1016\/j.ejmech.2026.118575_bib5","article-title":"In vitro activity of eravacycline against gram-negative Bacilli isolated in clinical laboratories worldwide from 2013 to 2017","volume":"64","author":"Morrissey","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib6","doi-asserted-by":"crossref","DOI":"10.15190\/d.2019.15","article-title":"FDA approved antibacterial drugs: 2018-2019","volume":"7","author":"Andrei","year":"2019","journal-title":"Discoveries"},{"key":"10.1016\/j.ejmech.2026.118575_bib7","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00018-011-0710-x","article-title":"Multifunctional cationic host defence peptides and their clinical applications","volume":"68","author":"Yeung","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2026.118575_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118575_bib9","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1038\/s41467-019-12364-6","article-title":"Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance","volume":"10","author":"Spohn","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118575_bib10","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118575_bib11","first-page":"24","article-title":"Antibiotic activity of Bacillus polymyxa","volume":"54","author":"Benedict","year":"1947","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejmech.2026.118575_bib12","first-page":"43","article-title":"Polymyxin: a new chemotherapeutic agent","volume":"81","author":"Stansly","year":"1947","journal-title":"Bull. Johns Hopkins Hosp."},{"key":"10.1016\/j.ejmech.2026.118575_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(48)90090-7","article-title":"Chemotherapy and pharmacology of aerosporin. a selective gram-negative antibiotic","volume":"251","author":"Brownlee","year":"1948","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118575_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/163611a0","article-title":"Nomenclature of polymyxin antibiotics","volume":"163","author":"Stansly","year":"1949","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118575_bib15","article-title":"The chemical basis for the classification of the polymyxins","volume":"43","author":"Jones","year":"1948","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.118575_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0021-9258(18)55594-0","article-title":"Polypeptin; purification, molecular weight determination, and amino acid composition","author":"Hausmann","year":"1952","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib17","first-page":"495","article-title":"Structure of colimycin","volume":"43","author":"Dautrevaux","year":"1961","journal-title":"Bull Soc Chim Biol (Paris)"},{"key":"10.1016\/j.ejmech.2026.118575_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.jbchem.a128082","article-title":"The chemical structure of polymyxin E: the identities of polymyxin E1 with colistin A and of polymyxin E2 with colistin B","volume":"57","author":"Suzuki","year":"1965","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejmech.2026.118575_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/microorganisms9020442","article-title":"The history of Colistin resistance mechanisms in bacteria: progress and challenges","volume":"9","author":"Hamel","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2026.118575_bib20","first-page":"157","article-title":"Colistin: an antibiotic and its role in multiresistant Gram-negative infections","volume":"47","author":"Loho","year":"2015","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.ejmech.2026.118575_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.118575_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.00064-16","article-title":"Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes","volume":"30","author":"Poirel","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.118575_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/membranes10080181","article-title":"Polymyxins and bacterial membranes: a review of antibacterial activity and mechanisms of resistance","volume":"10","author":"Ayoub Moubareck","year":"2020","journal-title":"Membranes"},{"key":"10.1016\/j.ejmech.2026.118575_bib26","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure--activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","article-title":"Colistin, mechanisms and prevalence of resistance","volume":"31","author":"Bialvaei","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2026.118575_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7164\/antibiotics.54.595","article-title":"Isolation and structural characterization of colistin components","volume":"54","author":"Orwa","year":"2001","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1155\/2006\/901873","article-title":"Colistin: the phoenix arises","volume":"17","author":"Conly","year":"2006","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118575_bib30","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.00035-06","article-title":"Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa","volume":"50","author":"Bergen","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drup.2010.05.002","article-title":"Resistance to polymyxins: mechanisms, frequency and treatment options","volume":"13","author":"Falagas","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ejmech.2026.118575_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40560-015-0072-9","article-title":"Colistin for lung infection: an update","volume":"3","author":"Gurjar","year":"2015","journal-title":"J Intensive Care"},{"key":"10.1016\/j.ejmech.2026.118575_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/fmb.13.39","article-title":"Pharmacology of polymyxins: new insights into an \u2018old\u2019 class of antibiotics","volume":"8","author":"Velkov","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejmech.2026.118575_bib34","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3389\/fmicb.2016.01789","article-title":"Colistin in pig production: chemistry, mechanism of antibacterial action, microbial resistance emergence, and one health perspectives","volume":"7","author":"Rhouma","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118575_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1021\/jp064757+","article-title":"Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides","volume":"111","author":"Clausell","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2026.118575_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.idc.2016.02.005","article-title":"Agents of last resort: polymyxin resistance","volume":"30","author":"Kaye","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ejmech.2026.118575_bib37","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1006\/bbrc.1995.1722","article-title":"Direct vesicle-vesicle exchange of phospholipids mediated by polymyxin B","volume":"210","author":"Cajal","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2026.118575_bib38","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1021\/bi952703c","article-title":"Specificity for the exchange of phospholipids through polymyxin B mediated intermembrane molecular contacts","volume":"35","author":"Cajal","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118575_bib39","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/iai.64.12.4922-4927.1996","article-title":"Antiendotoxin activity of cationic peptide antimicrobial agents","volume":"64","author":"Gough","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2026.118575_bib40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the era of antibiotic resistance: an extended review (2000\u20132019)","volume":"9","author":"El-Sayed Ahmed","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ejmech.2026.118575_bib41","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm900999h","article-title":"Structure\u2212Activity relationships of polymyxin antibiotics","volume":"53","author":"Velkov","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijantimicag.2011.02.008","article-title":"Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii","volume":"37","author":"Park","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.118575_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria","volume":"5","author":"Olaitan","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118575_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijantimicag.2016.06.023","article-title":"Molecular mechanisms of polymyxin resistance: knowns and unknowns","volume":"48","author":"Baron","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.118575_bib45","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1128\/IAI.72.12.7107-7114.2004","article-title":"Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides","volume":"72","author":"Campos","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2026.118575_bib46","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.7164\/antibiotics.33.1551","article-title":"Selective cleavage of a peptide antibiotic, colistin by colistinase","volume":"33","author":"Koyama","year":"1980","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib47","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ddr.21990","article-title":"Beta-lactam resistance and the effectiveness of antimicrobial peptides against KPC-producing bacteria","volume":"83","author":"da Costa de Souza","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2026.118575_bib48","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib49","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AAC.49.11.4814-4815.2005","article-title":"Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration [4]","volume":"49","author":"Li","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007726","article-title":"Heteroresistance: a cause of unexplained antibiotic treatment failure?","volume":"15","author":"Band","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.118575_bib51","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International Consensus Guidelines for the optimal use of the polymyxins: endorsed by the American College of clinical pharmacy (ACCP), European society of clinical microbiology and infectious diseases (ESCMID), infectious diseases society of America (ID","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2026.118575_bib53","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1093\/cid\/ciaa121","article-title":"Clinical and laboratory standards institute and European Committee on antimicrobial susceptibility testing position statements on polymyxin B and colistin clinical breakpoints","volume":"71","author":"Satlin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2012.07.010","article-title":"Pharmacokinetics and pharmacodynamics of \u2018old\u2019 polymyxins: what is new?","volume":"74","author":"Bergen","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib55","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkn425","article-title":"In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae","volume":"62","author":"Poudyal","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/AAC.00766-07","article-title":"Colistin heteroresistance in acinetobacter and its association with previous colistin therapy","volume":"52","author":"Hawley","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib57","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1128\/AAC.05028-11","article-title":"Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula","volume":"55","author":"Bergen","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dkm511","article-title":"Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"61","author":"Bergen","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib59","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/AAC.01571-06","article-title":"Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an In vitro Pharmacokinetic\/Pharmacodynamic model","volume":"51","author":"Chun-Hong","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.coph.2011.07.004","article-title":"Dosing of colistin-back to basic PK\/PD","volume":"11","author":"Bergen","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118575_bib61","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/bcp.14576","article-title":"Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions","volume":"87","author":"Yu","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118575_bib62","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.cmi.2020.03.016","article-title":"Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria","volume":"26","author":"Kristoffersson","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2026.118575_bib63","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40262-025-01488-2","article-title":"A systematic review of pharmacokinetic studies of Colistin and polymyxin B in adult populations","volume":"64","author":"Zamri","year":"2025","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2026.118575_bib64","series-title":"Springer International Publishing","first-page":"219","author":"Nation","year":"2019"},{"key":"10.1016\/j.ejmech.2026.118575_bib65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF01901127","article-title":"The chemistry of the polymyxin antibiotics","volume":"22","author":"Vogler","year":"1966","journal-title":"Experientia"},{"key":"10.1016\/j.ejmech.2026.118575_bib66","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1128\/AAC.00405-08","article-title":"Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents","volume":"52","author":"Vaara","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1034\/j.1399-3011.1999.00045.x","article-title":"Solid-phase total synthesis of polymyxin B1","volume":"53","author":"Sharma","year":"1999","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ejmech.2026.118575_bib68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1034\/j.1399-3011.2003.00061.x","article-title":"Solid-phase synthesis of polymyxin B1 and analogues via a safety-catch approach","volume":"61","author":"de Visser","year":"2003","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ejmech.2026.118575_bib69","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.tetlet.2016.03.055","article-title":"An improved and efficient strategy for the total synthesis of a colistin-like peptide","volume":"57","author":"Suhas","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2026.118575_bib70","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1248\/cpb.57.240","article-title":"Contribution of each amino acid residue in polymyxin B(3) to antimicrobial and lipopolysaccharide binding activity","volume":"57","author":"Kanazawa","year":"2009","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib71","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/acs.jmedchem.2c01915","article-title":"Critical role of position 10 residue in the polymyxin antimicrobial activity","volume":"66","author":"Patil","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib72","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41467-022-29234-3","article-title":"A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens","volume":"13","author":"Roberts","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118575_bib73","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm0000057","article-title":"Structure\u2212Function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria","volume":"43","author":"Tsubery","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib74","first-page":"175","article-title":"Synthesis and characterization of the colistin peptide polymyxin E1 and related antimicrobial peptides","volume":"57","author":"Kline","year":"2001","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.ejmech.2026.118575_bib75","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1021\/jm400416u","article-title":"Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections","volume":"56","author":"V Magee","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib76","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/ja00497a032","article-title":"Chemistry of polymer-bound o-benzyne. Frequency of encounter between substituents on crosslinked polystyrenes","volume":"101","author":"Mazur","year":"1979","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118575_bib77","doi-asserted-by":"crossref","first-page":"10579","DOI":"10.1021\/ja9705755","article-title":"IBTM-containing gramicidin S analogues: evidence for IBTM as a suitable type II\u2018 \u03b2-Turn Mimetic1,2","volume":"119","author":"Andreu","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118575_bib78","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0040-4039(93)85003-F","article-title":"A novel, convenient, three-dimensional orthogonal strategy for solid-phase synthesis of cyclic peptides","volume":"34","author":"Kates","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2026.118575_bib79","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acs.jmedchem.5b01593","article-title":"Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B","volume":"59","author":"Gallardo-Godoy","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib80","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1016\/j.tetlet.2015.06.056","article-title":"A new strategy for total solid-phase synthesis of polymyxins","volume":"56","author":"Xu","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2026.118575_bib81","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1021\/jm991031b","article-title":"Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling Study","volume":"42","author":"Pristov\u0161ek","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib82","doi-asserted-by":"crossref","first-page":"11498","DOI":"10.1074\/jbc.M806587200","article-title":"Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy","volume":"284","author":"Mares","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1476-5381.1967.tb01946.x","article-title":"Sodium sulphomethyl derivatives of polymyxins","volume":"29","author":"Beveridge","year":"1967","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib84","first-page":"54","article-title":"Chemical modification of peptide antibiotics : part VII--Biological activity of derivatives of polymyxin B","volume":"15","author":"Srinivasa","year":"1978","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2026.118575_bib85","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/AAC.8.1.95","article-title":"Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B","volume":"8","author":"Schindler","year":"1975","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib86","first-page":"112","article-title":"Essential amino groups of polymyxin B","volume":"17","author":"Srinivasa","year":"1980","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2026.118575_bib87","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.7164\/antibiotics.29.1349","article-title":"Broad-spectrum derivatives of polymyxin B and colistin","volume":"29","author":"Witzke","year":"1976","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/znb-1970-0137","article-title":"Preparation of biologically active mono-N-acetyl (14C)-derivatives of the membrane-specific polypeptide antibiotic polymyxin B","volume":"25","author":"Teuber","year":"1970","journal-title":"Z Naturforsch B"},{"key":"10.1016\/j.ejmech.2026.118575_bib89","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1016\/S0960-894X(98)00612-X","article-title":"Selective chemical modifications of polymyxin B","volume":"8","author":"Weinstein","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118575_bib90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1248\/yakushi1947.92.2_129","article-title":"[studies on the compounds related to colistin. V. Synthesis and pharmacological activity of colistin analogues]","volume":"92","author":"Kurihara","year":"1972","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejmech.2026.118575_bib91","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0021-9673(00)82091-9","article-title":"Isolation and characterization of three new polymyxins in polymyxins B and E by high-performance liquid chromatography","volume":"218","author":"Elverdam","year":"1981","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejmech.2026.118575_bib92","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0021-9673(01)00585-4","article-title":"Isolation and structural characterization of polymyxin B components","volume":"912","author":"Orwa","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejmech.2026.118575_bib93","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1246\/bcsj.77.1915","article-title":"The contribution of the N-Terminal structure of polymyxin B peptides to antimicrobial and lipopolysaccharide binding activity","volume":"77","author":"Sakura","year":"2004","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2026.118575_bib94","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1246\/bcsj.80.543","article-title":"Chemical conversion of natural polymyxin B and colistin to their N-Terminal derivatives","volume":"80","author":"Okimura","year":"2007","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2026.118575_bib95","first-page":"1767","article-title":"Chemical synthesis and characterization of n-Fattyacyl mono-aminoacyl derivatives of Colistin Nonapeptide","volume":"38","author":"Chihara","year":"1974","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib96","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/00021369.1974.10861184","article-title":"Chemical synthesis, isolation and characterization of \u03b1-N-Fattyacyl colistin nonapeptide with special reference to the correlation between antimicrobial activity and carbon number of fattyacyl moiety","volume":"38","author":"Chihara","year":"1974","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib97","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3389\/fmicb.2019.01689","article-title":"Polymyxins and their potential next generation as therapeutic antibiotics","volume":"10","author":"Vaara","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118575_bib98","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/acsinfecdis.9b00217","article-title":"Design of next generation polymyxins with lower toxicity: the discovery of SPR206","volume":"5","author":"Brown","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib99","article-title":"In vitro potency and spectrum of the novel Polymyxin MRX-8 tested against clinical isolates of gram-negative bacteria","volume":"66","author":"R","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X","article-title":"Soft drug design: general principles and recent applications","volume":"20","author":"Bodor","year":"2000","journal-title":"Med. Res. Rev."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118575_bib101","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41467-022-29234-3","article-title":"A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens","volume":"13","author":"Roberts","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118575_bib102","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1039\/D3MD00456B","article-title":"Semisynthetic polymyxins with potent antibacterial activity and reduced kidney cell toxicity","volume":"14","author":"Slingerland","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib103","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1177\/1060028015595643","article-title":"Head and neck hyperpigmentation probably associated with polymyxin B therapy","volume":"49","author":"Zavascki","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118575_bib104","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2174\/1568026043388105","article-title":"The search for molecular determinants of LPS inhibition by proteins and peptides","volume":"4","author":"Pristovsek","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127163","article-title":"Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity","volume":"30","author":"Brown","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118575_bib106","first-page":"3385","article-title":"Novel synthetic polymyxins kill Gram-positive bacteria","volume":"73","author":"Rudilla","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bio.810","article-title":"Synthesis and membrane action of polymyxin B analogues","volume":"20","author":"Clausell","year":"2005","journal-title":"Luminescence"},{"key":"10.1016\/j.ejmech.2026.118575_bib108","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7164\/antibiotics.37.926","article-title":"Studies on the selectivity of action of colistin, colistin nonapeptide and colistin heptapeptide on the cell envelope of Escherichia coli","volume":"37","author":"Ito-Kagawa","year":"1984","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib109","doi-asserted-by":"crossref","first-page":"634","DOI":"10.7164\/antibiotics.36.634","article-title":"Bu-2470, a new peptide antibiotic complex. II. Structure determination of Bu-2470 A, B1, B2a and B2b","volume":"36","author":"Sugawara","year":"1983","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7164\/antibiotics.28.379","article-title":"EM49, a new peptide antibiotic IV. The structure of EM49","volume":"28","author":"Parker","year":"1975","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib111","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7164\/antibiotics.33.182","article-title":"Isolation of octapeptin D (studies on antibiotics from the genus Bacillus. XXVII)","volume":"33","author":"Shoji","year":"1980","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib112","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1021\/bi010035r","article-title":"Cyclization of backbone-substituted peptides catalyzed by the thioesterase domain from the tyrocidine nonribosomal peptide synthetase","volume":"40","author":"Trauger","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118575_bib113","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/0-306-46831-X_18","article-title":"Structure activity relationship study of polymyxin B nonapeptide","volume":"479","author":"Tsubery","year":"2000","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2026.118575_bib114","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41429-023-00606-1","article-title":"Design, synthesis and antibacterial activity of novel colistin derivatives with thioether bond-mediated cyclic scaffold","volume":"76","author":"Li","year":"2023","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2026.118575_bib115","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1128\/AAC.48.9.3349-3357.2004","article-title":"De novo design of potent antimicrobial peptides","volume":"48","author":"Frecer","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib116","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.00200-07","article-title":"Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant","volume":"51","author":"Sil","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib117","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1128\/AAC.43.6.1347","article-title":"Antimicrobial activities of amine- and guanidine-functionalized cholic acid derivatives","volume":"43","author":"Li","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib118","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1039\/C1CC16369H","article-title":"Mimicking an antimicrobial peptide polymyxin B by use of cyclodextrin","volume":"48","author":"Yamamura","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.118575_bib119","article-title":"Interaction of the antimicrobial peptide polymyxin B1 with both membranes of E. coli: a molecular dynamics Study","volume":"11","author":"Berglund","year":"2015","journal-title":"PLoS Comput Biol\u200f"},{"key":"10.1016\/j.ejmech.2026.118575_bib120","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1021\/acs.biochem.6b01063","article-title":"Through the lipopolysaccharide glass: a potent antimicrobial peptide induces phase changes in membranes","volume":"56","author":"Jefferies","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2026.118575_bib121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bpj.2019.11.008","article-title":"Polymyxin B loosens Lipopolysaccharide Bilayer but Stiffens Phospholipid Bilayer","volume":"118","author":"Fu","year":"2020","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2026.118575_bib122","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/acs.jcim.7b00271","article-title":"Polymyxin binding to the bacterial outer membrane reveals cation displacement and increasing membrane curvature in susceptible but not in resistant lipopolysaccharide chemotypes","volume":"57","author":"Santos","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118575_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00656-19","article-title":"\u201cPredicting phenotypic polymyxin resistance in Klebsiella pneumoniae through machine learning analysis of genomic data\u200f\u201d","volume":"5","author":"Macesic","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.ejmech.2026.118575_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183302","article-title":"How do cyclic antibiotics with activity against Gram-negative bacteria permeate membranes? A machine learning informed experimental study","volume":"1862","author":"Lee","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejmech.2026.118575_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107681","article-title":"PmxPred: a data-driven approach for the identification of active polymyxin analogues against gram-negative bacteria","volume":"168","author":"Wang","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.118575_bib126","author":"Machado"},{"key":"10.1016\/j.ejmech.2026.118575_bib127","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1039\/C7NP00023E","article-title":"Recent advances and perspectives in the design and development of polymyxins","volume":"34","author":"Rabanal","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.118575_bib128","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00935-19","article-title":"Outer membrane interaction kinetics of new polymyxin B analogs in Gram-Negative Bacilli","volume":"63","author":"Akhoundsadegh","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/molecules24030553","article-title":"Structure-Function studies of polymyxin B lipononapeptides","volume":"24","author":"Gallardo-Godoy","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118575_bib130","doi-asserted-by":"crossref","first-page":"e02391","DOI":"10.1128\/AAC.02391-16","article-title":"Role of renal drug exposure in polymyxin B-Induced nephrotoxicity","volume":"61","author":"Manchandani","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib131","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1021\/ac504516k","article-title":"Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach","volume":"87","author":"Azad","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib132","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/cc3995","article-title":"Toxicity of polymyxins: a systematic review of the evidence from old and recent studies","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejmech.2026.118575_bib133","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/acschemneuro.8b00300","article-title":"Molecular mechanisms of neurotoxicity induced by polymyxins and chemoprevention","volume":"10","author":"Dai","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118575_bib134","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antibiotics8010024","article-title":"Polymyxin acute kidney injury: dosing and other strategies to reduce toxicity","volume":"8","author":"Nation","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ejmech.2026.118575_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1537972","article-title":"Case report: polymyxin E-associated reversible leukopenia","volume":"16","author":"Wan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.118575_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107035","article-title":"Battle of polymyxin induced nephrotoxicity: polymyxin B versus colistin","volume":"63","author":"Ball\u0131","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2026.118575_bib137","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1186\/s12879-021-06719-y","article-title":"Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections","volume":"21","author":"Xia","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117839","article-title":"Colistin treatment causes neuronal loss and cognitive impairment via ros accumulation and neuronal plasticity alterations","volume":"183","author":"Guzman","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118575_bib139","article-title":"A series of clinical cases highlighting cardiotoxicity induced by polymyxin B","volume":"21","author":"Patel","year":"2025","journal-title":"Emergency Care Journal"},{"key":"10.1016\/j.ejmech.2026.118575_bib140","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jac\/dkp331","article-title":"Pharmacokinetics of novel antimicrobial cationic peptides NAB 7061 and NAB 739 in rats following intravenous administration","volume":"64","author":"Ali","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib141","first-page":"ofac492","article-title":"A phase 1 study of the safety, tolerability, and pharmacokinetics of multiple doses of the lipopeptide QPX9003 in healthy adult subjects\u201d","volume":"9","author":"Griffith","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib142","doi-asserted-by":"crossref","first-page":"15878","DOI":"10.1021\/acs.jmedchem.2c01528","article-title":"Synthesis and evaluation of polymyxins bearing reductively labile disulfide-linked lipids","volume":"65","author":"Slingerland","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118575_bib143","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.00739-21","article-title":"Single- and multiple-ascending-dose study of the safety, tolerability, and pharmacokinetics of the polymyxin derivative SPR206","volume":"65","author":"Bruss","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib144","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/antibiotics13040354","article-title":"Pharmacokinetics and nephrotoxicity of polymyxin MRX-8 in rats: a novel agent against resistant gram-negative bacteria","volume":"13","author":"Qu","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.118575_bib145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/pharmaceutics16030389","article-title":"Tobramycin reduces pulmonary toxicity of polymyxin B via inhibiting the Megalin-Mediated drug uptake in the human lung epithelial cells","volume":"16","author":"Ahmed","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.118575_bib188","article-title":"Synergistic combinations of antimicrobial peptides and conventional antibiotics: a strategy to delay resistance emergence in WHO priority bacteria","volume":"100104","author":"Roque-Borda","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2026.118575_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105328","article-title":"Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury","volume":"163","author":"Sisay","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.118575_bib147","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.12998\/wjcc.v10.i31.11466","article-title":"Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: a meta-analysis","volume":"10","author":"Wang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.ejmech.2026.118575_bib148","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1128\/AAC.00254-13","article-title":"Megalin contributes to kidney accumulation and nephrotoxicity of Colistin","volume":"57","author":"Suzuki","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib149","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02391-16","article-title":"Role of renal drug exposure in polymyxin B-Induced nephrotoxicity","volume":"61","author":"Manchandani","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jac\/dkv340","article-title":"Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins","volume":"71","author":"Lu","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib151","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/acsinfecdis.3c00630","article-title":"Recent advances in the development of polymyxin antibiotics: 2010\u20132023","volume":"10","author":"Slingerland","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib152","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00018-022-04316-z","article-title":"Inwardly rectifying potassium channels mediate polymyxin-induced nephrotoxicity","volume":"79","author":"Lu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2026.118575_bib153","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/AAC.04869-14","article-title":"Major pathways of polymyxin-induced apoptosis in Rat kidney proximal tubular cells","volume":"59","author":"Azad","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161057","article-title":"Polymyxin B nephrotoxicity: from organ to cell damage","volume":"11","author":"Vattimo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118575_bib155","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1002\/tox.24376","article-title":"Tetrahydrocurcumin Attenuates polymyxin B sulfate-induced HK-2 cells apoptosis by inhibiting endoplasmic Reticulum stress-mediated PERK\/eIF2\u03b1\/ATF4\/CHOP signaling pathway axis","volume":"39","author":"Chen","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ejmech.2026.118575_bib156","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/antibiotics13060530","article-title":"Comparison of the impact of VRP-034 and polymyxin B upon markers of Kidney Injury in human proximal tubule monolayers in vitro","volume":"13","author":"Pye","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.118575_bib157","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/antibiotics10040359","article-title":"Polymyxin B-Induced kidney injury assessment of a novel formulation of polymyxin B (VRP-034) in rats","volume":"10","author":"Roy","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.118575_bib158","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13054-022-04195-7","article-title":"An area under the concentration\u2013time curve threshold as a predictor of efficacy and nephrotoxicity for individualizing polymyxin B dosing in patients with carbapenem-resistant gram-negative bacteria","volume":"26","author":"Yang","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejmech.2026.118575_bib159","article-title":"Evaluation of polymyxin B AUC\/MIC ratio for dose optimization in patients with carbapenem-resistant Klebsiella pneumoniae infection","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118575_bib160","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/AAC.01741-13","article-title":"Pharmacokinetics of Colistin methanesulfonate and formed Colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis","volume":"58","author":"Koomanachai","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib161","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1128\/AAC.00756-06","article-title":"Defining the dosage units for Colistin methanesulfonate: urgent need for international harmonization","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib162","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of Colistin methanesulfonate and formed Colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib163","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-0034-1398390","article-title":"Colistin: how should it be dosed for the critically ill?","volume":"36","author":"Landersdorfer","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2026.118575_bib164","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antibiotics8010024","article-title":"Polymyxin acute kidney injury: dosing and other strategies to reduce toxicity","volume":"8","author":"Nation","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.118575_bib165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11274-020-02873-8","article-title":"Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital","volume":"36","author":"Thet","year":"2020","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.118575_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05093-22","article-title":"Prevalence and clinical consequences of Colistin heteroresistance and evolution into full resistance in carbapenem-resistant Acinetobacter baumannii","volume":"11","author":"Kon","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2026.118575_bib167","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fmicb.2019.00042","article-title":"Variation in mutant prevention concentrations","volume":"10","author":"Gianvecchio","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118575_bib168","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/toxsci\/kft247","article-title":"Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers","volume":"137","author":"Keirstead","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2026.118575_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2013\/394582","article-title":"New biomarkers for the quick detection of Acute Kidney injury","volume":"2013","author":"Simsek","year":"2013","journal-title":"ISRN Nephrol"},{"key":"10.1016\/j.ejmech.2026.118575_bib170","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01735-17","article-title":"Evaluation of urinary KIM-1 for prediction of polymyxin B-Induced nephrotoxicity","volume":"61","author":"Babic","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib171","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00985-17","article-title":"Gelofusine ameliorates colistin-induced nephrotoxicity","volume":"61","author":"Sivanesan","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib172","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00219-24","article-title":"Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip model","volume":"68","author":"Payasi","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib173","article-title":"The novel polymyxin analogue SPR206 exhibits higher activity than colistin against both colistin-susceptible and colistin-resistant strains of Acinetobacter baumannii","volume":"69","author":"Outeda-Garc\u00eda","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.118575_bib174","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15386-1","article-title":"Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin\u2013sulbactam combination therapy","volume":"12","author":"Srisakul","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118575_bib175","article-title":"A small-molecule inhibitor of the Anthranilyl-CoA synthetase PqsA for the treatment of multidrug-resistant Pseudomonas aeruginosa","volume":"10","author":"Chen","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2026.118575_bib176","article-title":"\u201c Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin In Vitro and In Vivo \u201d","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2026.118575_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-02875-z","article-title":"Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics","volume":"9","author":"MacNair","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118575_bib178","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.118575_bib179","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.7150\/thno.45951","article-title":"Melatonin overcomes MCR-mediated colistin resistance in Gram-negative pathogens","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.118575_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202407764","article-title":"Allenamides as a powerful tool to incorporate diversity: thia-michael lipidation of semisynthetic peptides and access to \u03b2 \u2010Keto amides","volume":"63","author":"Na","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118575_bib181","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202403140","article-title":"A fluorous peptide amphiphile with potent antimicrobial activity for the treatment of MRSA\u2010induced sepsis and chronic wound infection","volume":"63","author":"Hu","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118575_bib182","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1002\/anie.202104921","article-title":"Selective bacterial targeting and infection\u2010triggered release of antibiotic Colistin conjugates","volume":"60","author":"Tegge","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118575_bib183","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202501299","article-title":"Antimicrobial peptide\u2010peptoid macrocycles from the polymyxin B2 chemical space","volume":"64","author":"Bonvin","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118575_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202425588","article-title":"Saarvienin A\u2014A novel glycopeptide with potent activity against drug\u2010resistant bacteria","volume":"64","author":"Kaur","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118575_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202408360","article-title":"A targeted click-to-release activation of the Last\u2010Resort Antibiotic Colistin reduces its renal cell toxicity","volume":"63","author":"Charoenpattarapreeda","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118575_bib186","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202214086","article-title":"Turning on the antimicrobial activity of gold nanoclusters against multidrug\u2010resistant bacteria","volume":"62","author":"Ndugire","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.118575_bib187","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202422270","article-title":"Gromomycins: an unprecedented class of triterpene antibiotics produced by a novel biosynthetic pathway","volume":"64","author":"Tistechok","year":"2025","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:11:22Z","timestamp":1778634682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":188,"alternative-id":["S0223523426000206"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118575","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure function and design of polymyxins to enable safer and more potent anti Gram negative agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118575"}}